Impact of Sangbaipi decoction and acupuncture combination on acute inflammatory response and stress injury in elderly patients with chronic obstructive pulmonary disease

This study aims to explore the impact of Sangbaipi Decoction (SBPD) in combination with acupuncture on chronic obstructive pulmonary disease (COPD) among the elderly, thereby offering valuable insights for clinical applications. A total of 128 COPD patients admitted to our hospital between July 2023 and July 2024 were recruited for this research. Of these, 68 patients undergoing conventional integrated Chinese and Western medicine rehabilitation therapy constituted the control group. The remaining 60 patients, received SBPD therapy based on the control group's regimen, forming the observation group. No significant difference was observed in the overall treatment efficacy between the two groups (P>0.05). However, the duration for the disappearance of cough and wheezing was significantly shorter in the observation group compared to the control group (P<0.05). Additionally, the observation group demonstrated superior pulmonary function and blood gas parameters after treatment, accompanied by lower levels of airway inflammatory factors and malondialdehyde as compared to the control group (P<0.05). These results suggest that SBPD combined with acupuncture can effectively shorten the rehabilitation duration of elderly COPD patients, enhance their lung and blood gas functions, and mitigate the inflammatory response.